» Articles » PMID: 35414784

ERK-mediated Cytoplasmic Retention of USP11 Contributes to Breast Cancer Cell Proliferation by Stabilizing Cytoplasmic P21

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2022 Apr 13
PMID 35414784
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer ranks as the most frequently diagnosed cancer among women worldwide. Elevated cytoplasmic p21 levels are often found in breast cancer tissues and related to a poor prognosis. However, the underlying mechanisms that lead to the stabilization of cytoplasmic p21 protein, which normally has a very short half-life, remain obscure. In this study, we found that there was a strong correlation between p21 and USP11 in the cytoplasm of breast cancer tissues and cells. Furthermore, we revealed that ERK1/2 phosphorylated USP11 at the Ser905 site, which promoted the cytoplasmic localization of USP11. In the cytoplasm, USP11 colocalized and interacted with p21. As a result, USP11 catalyzed the removal of polyubiquitin chains bound to cytoplasmic p21 and resulted in its stabilization. Functionally, USP11-mediated stabilization of cytoplasmic p21 induced breast cancer cell proliferation and . Our findings provide the first evidence that ubiquitinated p21 in the cytoplasm can be recycled through USP11-mediated deubiquitination, and we identified the USP11-p21 axis in the cytoplasm as a potential therapeutic target for breast cancer control.

Citing Articles

The USP11/Nrf2 positive feedback loop promotes colorectal cancer progression by inhibiting mitochondrial apoptosis.

Lu Y, Wei W, Li M, Chen D, Li W, Hu Q Cell Death Dis. 2024; 15(12):873.

PMID: 39617751 PMC: 11609304. DOI: 10.1038/s41419-024-07188-2.


The deubiquitinating enzyme USP11 regulates breast cancer progression by stabilizing PGAM5.

Zhang N, Wang Q, Lu Y, Wang F, He Z Breast Cancer Res. 2024; 26(1):135.

PMID: 39300548 PMC: 11414074. DOI: 10.1186/s13058-024-01892-9.


USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target.

Li S, Song Y, Wang K, Liu G, Dong X, Yang F Cell Death Discov. 2023; 9(1):338.

PMID: 37679322 PMC: 10485055. DOI: 10.1038/s41420-023-01629-1.

References
1.
Starostina N, Simpliciano J, McGuirk M, Kipreos E . CRL2(LRR-1) targets a CDK inhibitor for cell cycle control in C. elegans and actin-based motility regulation in human cells. Dev Cell. 2010; 19(5):753-64. PMC: 3053091. DOI: 10.1016/j.devcel.2010.10.013. View

2.
Ma J, Li R, Wang J . Characterization of a prognostic four‑gene methylation signature associated with radiotherapy for head and neck squamous cell carcinoma. Mol Med Rep. 2019; 20(1):622-632. PMC: 6579992. DOI: 10.3892/mmr.2019.10294. View

3.
Zhou Z, Luo A, Shrivastava I, He M, Huang Y, Bahar I . Regulation of XIAP Turnover Reveals a Role for USP11 in Promotion of Tumorigenesis. EBioMedicine. 2017; 15:48-61. PMC: 5233825. DOI: 10.1016/j.ebiom.2016.12.014. View

4.
Yang H, Park D, Ryu J, Park T . USP11 degrades KLF4 via its deubiquitinase activity in liver diseases. J Cell Mol Med. 2021; 25(14):6976-6987. PMC: 8278108. DOI: 10.1111/jcmm.16709. View

5.
Dai M, Al-Odaini A, Arakelian A, Rabbani S, Ali S, Lebrun J . A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion. Breast Cancer Res. 2012; 14(5):R127. PMC: 4053104. DOI: 10.1186/bcr3322. View